Apart from PD-1/PD-L1 signaling, there is a lack of knowledge regarding other immune checkpoint molecules, including the CD200/CD200R axis, concerning MCC evolution and prognosis [9,10,11]. The gene discussed is CD200; the disease is Merkel cell skin cancer.